Supporting your live biotherapeutic product with flexibility and unmatched experience

Live biotherapeutic products (LBPs) are changing the lives of patients with conditions affecting the gut, including inflammatory bowel disease (IBD) and Clostridioides difficile infection (CDI).

Fed Bio leverages expertise gained from over 10 years of experience to develop and manufacture your LBP and deliver it to patients with certainty.

Leveraging our experience working with more than 215 species, we provide the flexibility to support your LBP through every step of the journey, from process development to clinical supply to commercial manufacturing.